Daicel Corporation carries a market capitalization of 2.04B, placing it among publicly traded companies globally. Its enterprise value stands at 545.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.04B |
| Enterprise Value | 545.46B |
Daicel Corporation currently has 276.12M shares outstanding.
| Shares Outstanding | 276.12M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Daicel Corporation trades at a trailing price-to-earnings ratio of 11.99. The price-to-sales ratio is 1.09, and the price-to-book ratio stands at 1.11.
| PE Ratio | 11.99 |
| PS Ratio | 1.09 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Daicel Corporation trades at an EV/EBITDA multiple of 15.24 and an EV/FCF ratio of 881.51. The EV/Sales ratio of 1.90 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.24 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.90 |
| EV / EBITDA | 15.24 |
| EV / EBIT | 15.24 |
| EV / FCF | 881.51 |
Daicel Corporation maintains a current ratio of 2.24, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 71.94, indicating elevated leverage, while an interest coverage ratio of 42.91 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.24 |
| Quick Ratio | 0.38 |
| Debt / Equity | 71.94 |
| Debt / EBITDA | 7.89 |
| Interest Coverage | 42.91 |
Daicel Corporation posts a return on equity of 9.82 and a return on invested capital of 3.95.
| Return on Equity (ROE) | 9.82 |
| Return on Assets (ROA) | 3.19 |
| Return on Invested Capital (ROIC) | 3.95 |
| Return on Capital Employed (ROCE) | 4.56 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.10 |
Over the trailing twelve months, Daicel Corporation has paid 9.28B in income taxes, reflecting an effective tax rate of 25.81.
| Income Tax | 9.28B |
| Effective Tax Rate | 25.81 |
Daicel Corporation's stock has declined approximately -6.10329% over the past 52 weeks. The 50-day moving average sits at 8.44, while the 200-day moving average is 8.46.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.10329% |
| 50-Day Moving Average | 8.44 |
| 200-Day Moving Average | 8.46 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Daicel Corporation generated 287.05B in revenue and converted that into 26.08B in net income, yielding earnings per share of 104.53. EBITDA reached 35.79B, while operating income came in at 35.79B.
| Revenue | 287.05B |
| Gross Profit | 84.35B |
| Operating Income | 35.79B |
| Pretax Income | 35.96B |
| Net Income | 26.08B |
| EBITDA | 35.79B |
| EBIT | 35.79B |
| Earnings Per Share (EPS) | 104.53 |
Daicel Corporation holds 64.79B in cash and equivalents against 282.24B in total debt, resulting in a net debt position of 217.44B. Total book value stands at 280.85B, with working capital of 213.51B providing operational flexibility.
| Cash & Cash Equivalents | 64.79B |
| Total Debt | 282.24B |
| Net Debt | 217.44B |
| Equity (Book Value) | 280.85B |
| Book Value Per Share | 1,100.24 |
| Working Capital | 213.51B |
Daicel Corporation operates with a gross margin of 29.38, reflecting its pricing power and cost economics. The operating margin of 12.47 and net profit margin of 9.09 provide insight into operational efficiency.
| Gross Margin | 29.38 |
| Operating Margin | 12.47 |
| Pretax Margin | 12.53 |
| Profit Margin | 9.09 |
| EBITDA Margin | 12.47 |
Daicel Corporation posts an Altman Z-Score of 1.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.66 |